Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 4Pain 4Neoplasms 4Nausea 3Pancreatic Neoplasms 2Cancer Pain 2Breast Neoplasms 2Taste Disorders 1Parasomnias 1Olfaction Disorders 1Marijuana Abuse 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1

Interventions

Morphine 16Oxycodone 14Fentanyl 10Methadone 7nabiximols 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Hydromorphone 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Buprenorphine 3Transcranial Direct Current Stimulation 2Tapentadol 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiosurgery 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cancer Pain × Dronabinol × Clear all
NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed
11 enrolled

Cancer Pain

NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

LaSanta S A S

Phase 1/2 Unknown
334 enrolled

Cancer Pain, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡